.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Johnson and Johnson
Colorcon
Chubb
Farmers Insurance
Queensland Health
Teva
Fuji
Cerilliant
Chinese Patent Office

Generated: September 19, 2017

DrugPatentWatch Database Preview

Sevoflurane - Generic Drug Details

« Back to Dashboard

What are the generic sources for sevoflurane and what is the scope of sevoflurane freedom to operate?

Sevoflurane
is the generic ingredient in three branded drugs marketed by Halocarbon Prods, Piramal Critical, Abbvie, Shanghai Hengrui, and Baxter Hlthcare, and is included in five NDAs. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Sevoflurane has ninety patent family members in thirty-seven countries.

There are five drug master file entries for sevoflurane. Four suppliers are listed for this compound.

Summary for Generic Name: sevoflurane

Tradenames:3
Patents:4
Applicants:5
NDAs:5
Drug Master File Entries: see list5
Suppliers / Packagers: see list4
Bulk Api Vendors: see list40
Clinical Trials: see list463
Patent Applications: see list1,365
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:sevoflurane at DailyMed

Pharmacology for Ingredient: sevoflurane

Drug ClassGeneral Anesthetic
Physiological EffectGeneral Anesthesia
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Piramal Critical
SOJOURN
sevoflurane
LIQUID;INHALATION077867-001May 2, 2007ANRXNoNo► Subscribe► Subscribe► Subscribe
Abbvie
ULTANE
sevoflurane
LIQUID;INHALATION020478-001Jun 7, 1995ANRXYesYes► Subscribe► SubscribeY► Subscribe
Shanghai Hengrui
SEVOFLURANE
sevoflurane
LIQUID;INHALATION203793-001Nov 3, 2015ANRXNoNo► Subscribe► Subscribe► Subscribe
Halocarbon Prods
SEVOFLURANE
sevoflurane
LIQUID;INHALATION078650-001Nov 19, 2007ANRXNoNo► Subscribe► Subscribe► Subscribe
Abbvie
ULTANE
sevoflurane
LIQUID;INHALATION020478-001Jun 7, 1995ANRXYesYes► Subscribe► SubscribeY► Subscribe
Abbvie
ULTANE
sevoflurane
LIQUID;INHALATION020478-001Jun 7, 1995ANRXYesYes► Subscribe► SubscribeY► Subscribe
Baxter Hlthcare
SEVOFLURANE
sevoflurane
LIQUID;INHALATION075895-001Jul 2, 2002ANRXNoNo► Subscribe► Subscribe► Subscribe
Abbvie
ULTANE
sevoflurane
LIQUID;INHALATION020478-001Jun 7, 1995ANRXYesYes► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: sevoflurane

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie
ULTANE
sevoflurane
LIQUID;INHALATION020478-001Jun 7, 1995► Subscribe► Subscribe
Abbvie
ULTANE
sevoflurane
LIQUID;INHALATION020478-001Jun 7, 1995► Subscribe► Subscribe
Abbvie
ULTANE
sevoflurane
LIQUID;INHALATION020478-001Jun 7, 1995► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: sevoflurane

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,677,492 Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid► Subscribe
6,558,679 Container for an inhalation anesthetic► Subscribe
6,162,443 Container for an inhalation anesthetic► Subscribe
6,083,514 Polymethylpentene container for an inhalation anesthetic► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: sevoflurane

Country Document Number Estimated Expiration
Argentina019364► Subscribe
Japan2006143742► Subscribe
Czech Republic9902561► Subscribe
Israel130150► Subscribe
Canada2317126► Subscribe
Slovakia284243► Subscribe
European Patent Office1045686► Subscribe
Japan3183520► Subscribe
Argentina057610► Subscribe
Czech Republic295380► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Federal Trade Commission
AstraZeneca
Express Scripts
Novartis
QuintilesIMS
Healthtrust
Cerilliant
Argus Health
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot